- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/00 - Drugs for dermatological disorders
Patent holdings for IPC class A61P 17/00
Total number of patents in this class: 9261
10-year publication summary
|
356
|
326
|
542
|
578
|
779
|
732
|
800
|
758
|
647
|
345
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shiseido Company, Ltd. | 4095 |
119 |
| Galderma Research & Development | 405 |
89 |
| AMOREPACIFIC Corporation | 2823 |
64 |
| Osaka University | 3374 |
51 |
| Incyte Corporation | 1019 |
50 |
| Novartis AG | 10867 |
49 |
| Daiichi Sankyo Company, Limited | 1865 |
45 |
| L' Oréal | 5522 |
43 |
| The Regents of the University of California | 19868 |
42 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
41 |
| ELC Management LLC | 1061 |
40 |
| Boehringer Ingelheim International GmbH | 4695 |
38 |
| Kao Corporation | 4959 |
37 |
| Pierre Fabre Dermo-Cosmetique | 365 |
37 |
| Caregen Co., Ltd. | 308 |
36 |
| Takeda Pharmaceutical Company Limited | 2711 |
34 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
33 |
| Regeneron Pharmaceuticals, Inc. | 4246 |
33 |
| Pfizer Inc. | 3379 |
32 |
| Maruho Co., Ltd. | 95 |
32 |
| Other owners | 8316 |